Metastatic disease is the leading cause of death due to prostate cancer (PCa). Although the hypermethylated in cancer 1 (HIC1) gene has been observed to be epigenetically modified in PCa, its intrinsic role and mechanism in PCa metastasis still remain uncertain. Here, we show that hypermethylation of the HIC1 promoter markedly reduces its suppressive function in metastatic PCa tissues as compared with primary and adjacent normal prostate tissues, and is associated with poor patient survival. PCas in cancer-prone mice homozygous for a prostate-targeted Hic1 conditional knockout showed stronger metastatic behaviour than those in heterozygous mice, as a result of epithelial-mesenchymal transition (EMT). Moreover, impairment of HIC1 expression in PCa cells induced their migration and metastasis through EMT, by enhancing expression of Slug and CXCR4, both of which are critical to PCa metastasis; the CXCL12-CXCR4 axis promotes EMT by activating the extracellular signal-regulated kinase (ERK) 1/2 pathway. Taken together, our results suggest that evaluation of HIC1-CXCR4-Slug signalling may provide a potential predictor for PCa aggressiveness.
Introduction
Prostate cancer (PCa) is the most common malignant tumour in men in Western countries. Although PCa is not the most prevalent neoplasm in Chinese men, its incidence and mortality have both increased rapidly in recent years [1] . Most malignant PCas show invasive features, and patients subsequently suffer from distant metastasis, the leading cause of PCa-related death [2] . Multiple studies have identified several molecular alterations associated with invasive and metastatic PCa phenotypes, including loss or mutation of PTEN, TMPRSS2-ERG gene fusion, TP53 mutation, downregulation of NKX3.1, and upregulation of MYC and CXCR4 [3] [4] [5] [6] [7] [8] . Although systematic therapeutic approaches have reduced cancer-specific mortality, PCa still shows high rates of metastasis [6] . Dissecting the molecular mechanisms of PCa metastasis has therefore become central to improving the effects of therapy.
Epithelial-mesenchymal transition (EMT), during which cells switch from a non-mobile, epithelial phenotype to a highly mobile, mesenchymal phenotype, is widely considered to be a key step in the progression of primary tumours to metastases [9, 10] . The hallmark event of EMT is partial or complete loss of E-cadherin, which not only disrupts the interaction between epithelial cells, but also induces wide-ranging transcriptional and functional changes responsible for the EMT programme [11] . Some EMT-inducing transcription factors, including Zeb1, Zeb2, Snail, and Slug, have been identified as direct transcriptional repressors of E-cadherin [12] . Notably, several reports have indicated that elevated expression levels of these transcription factors are associated with invasive PCa410 M Hao et al hypermethylation in many types of human malignancy, including breast, liver, colorectal, lung and gastric cancer [17] [18] [19] [20] [21] . Other regulatory mechanisms are also involved in modulating the function and expression of HIC1, such as acetylation-SUMOylation switch by SIRT1 and positive transcriptional regulation by p53 and E2F1 [22] [23] [24] . Whereas mice with homozygous disruption of Hic1 die during embryogenesis or perinatally, mice with heterozygous deletion of the gene develop various malignant tumours [25] . HIC1 encodes a sequence-specific transcriptional repressor, which belongs to the BTB/POZ and C2H2 zinc finger family [26] . The N-terminal BTB/POZ domain of HIC1 is responsible for protein-protein interaction, and the C-terminal region binds to a specific DNA sequence named HIC1-responsive element (HiRE) with a GGCA core motif [27] . Several downstream target genes of HIC1 have been identified, involved in modulating angiogenesis, proliferation, the cell cycle, and metastasis, including CXCR7, LCN2, SIRT1, ATOH1, CCND1, and P57KIP2 [28] [29] [30] [31] [32] [33] . However, the role and mechanisms of HIC1 impairment in regulating PCa metastasis are still largely unknown.
Materials and methods

Cell culture
The human PCa cell lines LNCaP and DU145 were purchased from the American Type Culture Collection. The C4-2B cell line was originally obtained from K. Pienta (University of Michigan, MI, USA). LNCaP and C4-2B cells were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA, USA). DU145 cells were cultured in Dulbecco's modified Eagle's medium medium with 10% FBS. The cell lines were tested and authenticated by DNA typing in Shanghai Jiao-Tong University Analysis Core, and were cultured in a 37 ∘ C water-saturated 5% CO 2 atmosphere. Table S1 .
Generation of prostate conditional alleles of
Left intracardiac injections and in vivo metastasis assay
Left intracardiac injection of luciferase-labelled PCa cells (10 5 per mouse) was performed to determine metastasis. The detailed methodologies have been previously described [29] , and are outlined in supplementary material, Supplementary materials and methods.
Construction of lentiviral vectors and lentivirus packaging
These methodologies are described in supplementary material, Supplementary materials and methods.
Flow cytometry
To assay expression of CXCR4, 10 5 cells were incubated at room temperature for 30 min with 10 μl of non-specific isotype-matched control IgG (R&D, Minneapolis, MN, USA) and 8 μl of mouse monoclonal antibodies conjugated with APC fluorochrome (12G5; BD Biosciences, San Diego, CA, USA). Unbound antibodies were removed by washing the cells twice in phosphate-buffered saline. Cells were analysed with a FACScan (BD Biosciences), and the data were analysed with CellQuest software (BD Biosciences).
Cell invasion and migration assays
Cell invasion and migration were assayed by the use of BD Falcon cell culture inserts (8 μm, membrane coated or not coated with reconstituted extracellular matrix, respectively) (BD Biosciences). Additional details are given in supplementary material, Supplementary materials and methods.
Western blots
These methods are described in Supplementary materials and methods.
Luciferase reporter assays
The SLUG (SNAI2) and CXCR4 promoters and their truncated constructs were generated from genomic DNA of the human prostate epithelial cell line PrEC. All constructs and their mutants were inserted into the pGL3-basic reporter gene vector. Additional details are provided in [34] and supplementary material, Supplementary materials and methods.
Chromatin immunoprecipitation (ChIP)
ChIP was performed according to published protocols, with slight modifications [35, 36] 
Clinical dataset analysis
To compare HIC1 expression among PCa patient samples including adjacent normal, primary and metastasis tissues, the dataset GSE21034 was downloaded from the NCBI GEO. It was processed with Aroma Affymetrix with standard robust multi-array average background adjustment and quantile normalization [37] . Recurrence-free survival was compared between high and low HIC1 expression groups, with the median gene expression value as a bifurcating point. Evaluation of the methylation status of the HIC1 promoter and its correlation with expression level in The Cancer Genome Atlas (TCGA) human PCa samples were derived from the MethHC database [38] .
Statistical analysis
Numerical data are expressed as means ± standard deviations or means ± standard errors of the mean. Statistical differences between the means for the different groups were evaluated with two-tailed Student's t-tests. A log-rank test was performed to compare survival and recurrence. The number of bone metastases in control and experimental groups was calculated with Fisher's exact test. Image data of western blots and ChIP were quantified with Gel-pro analyser, and IHC images were processed with Image-pro Plus 6.0. Statistical significance was defined as p < 0.05. SPSS 11.5 software was used for all analyses.
Results
HIC1 loss in PCa is associated with the metastatic phenotype
We previously reported that the HIC1 promoter was highly methylated in PCa, resulting in silencing of HIC1 expression and impairment of its repressive function [29] . In the present study, using the TCGA database, we first analysed the methylation status of the HIC1 promoter and its expression level in 387 PCa patients. The HIC1 promoter was hypermethylated in tissues of PCa patients, as compared with adjacent normal prostate tissues (supplementary material, Figure S1A ). Moreover, the degree of methylation was negatively correlated with HIC1 mRNA expression, indicating that the promoter hypermethylation impaired HIC1 expression in PCa patients (supplementary material, Figure S1B ). Next, to assess the effect of HIC1 loss on PCa metastasis, HIC1 mRNA expression and prognosis were assessed by the use of Taylor's dataset, including normal prostate tissue, primary PCa and metastatic PCa with a median of 5 years of clinical follow-up. Kaplan-Meier analyses indicated earlier recurrence after radical prostatectomy in PCa patients with lower HIC1 expression than in those with higher HIC1 expression ( Figure 1A) . Notably, HIC1 expression was significantly reduced only in metastatic PCa tissues as compared with primary and adjacent normal prostate tissues ( Figure 1B ). These data suggest that HIC1 expression is closely related to PCa metastasis, and may serve as a pathological predictor for PCa aggressiveness.
To Figure S2C ). Taken together, these findings suggest that Hic1-null status is responsible for local invasion and metastasis of PCa.
HIC1 loss induces PCa metastasis through EMT
To explore how HIC1 loss promotes PCa metastasis, HIC1 was stably silenced in two metastatic PCa cell lines, i.e. C4-2B and DU145 (respectively referred to as C4-2B shctrl , C4-2B shHIC1-2 and C4-2B shHIC1-3 , and DU145 shctrl , DU145 shHIC1-2 and DU145 shHIC1-3 ). Supplementary material, Figure S3A indicates that silencing of HIC1 expression in both cells enhanced their migratory and invasive abilities. To further explore whether HIC1 modulates PCa metastasis in vivo, we tagged DU145
shctrl and DU145 shHIC1 cells with a luciferase gene by retrovirus infection. These tagged cells were then transplanted into BALB/c nude mice by intracardiac injection. Consistent with the in vitro assays, HIC1 silencing greatly promoted the metastatic potential of DU145 cells, regardless of whether the mouse was imaged, from the ventral surface, at 3 or 6 weeks ( Figure 2A ; supplementary material, Figure S3B ). Additionally, rescuing HIC1 expression in DU145 shHIC1 cells markedly decreased their invasive and metastatic potential (data not shown). Similar results were obtained with C4-2B
shctrl-shctrl and C4-2B shHIC1-shctrl cells ( Figure 3C , D). Moreover, bioluminescence imaging confirmed that the incidence of bone metastasis was higher in mice carrying C4-2B
shHIC1-shctrl cells than in those carrying C4-2B
shctrl-shctrl cells at 6 weeks after injection ( Figure 3E ).
Bone destruction is the main cause of morbidity of PCa patients [2] . Radiographic analysis and H&E staining further confirmed that mice inoculated with C4-2B
shHIC1-shctrl and DU145 shHIC1 cells showed apparent osseous destruction and colonizing tumour cells in shin bones, as compared with the respective control group ( Figure 2B, C) . Additionally, mice inoculated with C4-2B shHIC1-shctrl cells had shorter lifespans than those inoculated with C4-2B
shctrl-shctrl cells ( Figure 3F ). Taken together, these findings suggest that HIC1 silencing is responsible for PCa invasion and metastasis, in line with the results obtained in Pten PC−/− Hic1 PC−/− mice and as inferred from the clinical data.
EMT has been widely considered to be a key step in the metastasis of tumours, including PCa [39, 40] . Hence, we further investigated whether HIC1 silencing induces PCa progression through EMT. Upon HIC1 silencing, C4-2B and DU145 cells underwent EMT-like morphological changes (supplementary material, Figure  S3C ). In particular, the cells elongated and grew in loose colonies, in contrast to control cells, which stayed tightly attached and had a cuboidal shape. Next, we analysed the genome-wide transcriptome profiles of DU145 shctrl versus DU145 shHIC1-2 cells and C4-2B Applying a 1.5-fold screening criterion between cells with HIC1 silencing and controls, we identified 13 overlapping genes related to EMT in both cell types. The genes included nine downregulated epithelial marker genes and four upregulated mesenchymal marker genes in HIC1-silenced cells (supplementary material, Figure S4A ). As shown in Figure 2D , E-cadherin expression was markedly decreased in C4-2B shHIC1 and DU145 shHIC1 cells. In contrast, we observed increased expression of N-cadherin, vimentin and Slug, in agreement with the microarray assays. Similar results were obtained with LNCaP cells (supplementary material, Figure S4B ). Moreover, reduced expression of E-cadherin and enhanced expression of vimentin or N-cadherin in C4-2B shHIC1 cells were further confirmed by IF staining ( Figure 2E ; supplementary material, Figure S4C ). Taken together, these findings demonstrate that HIC1 silencing can induce PCa invasion and metastasis, potentially through EMT.
Finally, we investigated whether depletion of Hic1 in mouse neoplastic prostate epithelium is sufficient to initiate EMT. Immunohistochemical staining of epithelial markers (E-cadherin and CK8) and mesenchymal markers (N-cadherin and Slug) was subsequently assayed. Figure 2F and supplementary material, Figure S5 show that Hic1-null status initiated EMT as expected, accompanied by reduced staining of epithelial markers and accumulation of mesenchymal markers in Pten PC−/− Hic1 PC−/− mice (as compared with Pten PC−/− Hic1 PC+/+ mice). In summary, in vitro and in vivo data confirm that HIC1 loss plays a causal role in promoting PCa metastasis through EMT. transcriptional factors, such as Snail, Slug, Twist, and Zeb1/2 [9] . To determine whether HIC1 silencing modulates expression of these factors, we assayed their expression levels in C4-2B and DU145 cells by using reverse transcription quantitative PCR (RT-qPCR). In both cell lines, HIC1 silencing dramatically increased the expression of Slug, but had no effect on Snail and Zeb1/2 ( Figure 3A ), suggesting that Slug may be responsible for HIC1 impairment-induced EMT.
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To confirm that the EMT is mediated by an inverse HIC1-Slug relationship, we stably reduced Slug expression in C4-2B shHIC1 cells by short hairpin RNA (shRNA)-mediated knockdown. Knockdown of Slug in C4-2B shHIC1 cells significantly reversed the EMT induced by HIC1 loss ( Figure 3B ). Specifically, we observed re-expression of E-cadherin and downregulation of N-cadherin and vimentin. Notably, concomitant with this EMT reversion, Slug knockdown decreased the migratory and invasive abilities of C4-2B shHIC1 and DU145
shHIC1 cells (supplementary material, Figure  S6A ). To further confirm that Slug is involved in HIC1 loss-induced PCa progression in vivo, luciferase-tagged C4-2B
shctrl-shctrl , C4-2B shHIC1-shctrl and C4-2B
shHIC1-shSlug cells were transplanted into BALB/c nude mice. Figure 3C -E indicates that Slug knockdown reduced the PCa bone metastasis of HIC1-deficient cells. Moreover, Slug silencing markedly increased mouse survival ( Figure 3F ). In conclusion, these results indicate that Slug plays an important role in PCa metastasis through the EMT initiated by HIC1 loss.
The Slug gene is directly regulated by HIC1
Given the fact that HIC1 functions as a repressive transcription factor and directly binds to the promoters of its target genes [26] , we supposed that Slug might also be a direct target of HIC1. Indeed, supplementary material, Figure S7A shows 11 putative HIC1-binding sites (GGCA or TGCC) identified in the Slug promoter. To verify the functionality of these sites, the −1727 to +10 Slug promoter region was cloned into the pGL3 luciferase reporter plasmid, and a series of promoter/reporter fusion plasmids containing progressive 5expression vector, into C4-2B and DU145 cells, and the promoter activities were measured in luciferase reporter assays. In both cell lines, HIC1 expression markedly inhibited Slug promoter activity ( Figure 4A ). This ability of HIC1 to repress Slug promoter activity was noted in all tested constructs, including the −388/+10 truncation ( Figure 4B ), suggesting that the regulatory region involved in HIC1-mediated repression may be located within the −388-bp to +10-bp region, which contains two putative HIC1-binding sites: Δ1 and Δ2 ( Figure 4C ). We accordingly mutated both HiRE sites (GGCA to ATGA) to abolish HIC1 binding. Both mutated constructs significantly decreased the repressive capacity of HIC1 ( Figure 4C ). Finally, to determine whether the Slug promoter is indeed directly bound by HIC1, we performed ChIP assays. We utilized a polyclonal antibody targeting HIC1 to pull down endogenous HIC1 protein in C4-2B and DU145 cells. PCR primers for the genomic locus flanking the −388/+10 region of the Slug promoter and the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) promoter were designed; the latter primers were used for a negative control experiment. Figure 4D shows that the Slug promoter was enriched in HIC1-immunoprecipitated chromatin from C4-2B and DU145 cells, but absent from chromatin immunoprecipitated by the control rabbit IgG. Taken together, these data confirm that HIC1 directly represses Slug transcription.
HIC1 regulates CXCR4 expression in PCa
We previously reported that the chemokine receptor CXCR4 is responsible for distal spread of PCa, especially in bone tissue, where its cognate ligand CXCL12 is produced at a high level [8] . On the basis of the effects induced by HIC1 silencing in PCa, we investigated whether altered HIC1 expression could modulate CXCR4 expression. Figure 5A shows that HIC1 knockdown in C4-2B and LNCaP cells markedly enhanced expression of CXCR4. We also used CXCR7, a previously identified target gene of HIC1, as a positive control; silencing HIC1 elevated expression of CXCR7 in C4-2B cells assayed by flow cytometry (data not shown). Similarly, Pten PC−/− Hic1 PC−/− mice bearing PCa cells showed stronger expression of Cxcr4 than Pten PC−/− Hic1 PC+/− mice ( Figure 5B ). In contrast, overexpression of HIC1 apparently reduced the level of CXCR4 in C4-2B cells (supplementary material, Figure  S6B ). Consistent with previous studies, elevated expression of CXCR4 appears to be responsible for the HIC1 silencing-induced invasive phenotype of PCa (supplementary material, Figure S6C ). To define how HIC1 regulates CXCR4 expression, we constructed a series of CXCR4-based luciferase reporter constructs. These were cotransfected, with the pCDNA3.1-ctrl-His or pCDNA3.1-HIC1-His expression vector, into C4-2B and DU145 cells, and promoter activities were measured with luciferase reporter assays.
Ectopic HIC1 inhibited transcription driven by all constructs, i.e. 1356/+96, −678/+96, and −185/+96 ( Figure 5C ; supplementary material, Figure S7B ). The construct containing the shortest version of the CXCR4 promoter (−185/+96) contains two putative HiREs. We therefore constructed two mutated reporters, designated M1 and M2, to abolish HIC1 binding (supplementary material, Figure S7C ). The HIC1 repressive effect was relieved by the Δ1 construct only, suggesting that the putative first HiRE site in the CXCR4 promoter is essential for HIC1-mediated repression ( Figure 5D ). Finally, we performed ChIP assays, using PCR primers designed to amplify the region in the CXCR4 promoter mediating the repressive effects of HIC1. This CXCR4 promoter region was significantly enriched in the HIC1-immunoprecipitated C4-2B and DU145 chromatin, but absent from chromatin immunoprecipitated by control rabbit IgG ( Figure 5E ). These findings indicate that HIC1 regulates CXCR4 expression by directly targeting its promoter, and is potentially associated with PCa bone metastasis.
The CXCL12-CXCR4 axis modulates EMT
Owing to the critical roles of Slug and CXCR4 in promoting PCa bone metastasis, we next evaluated the underlying mechanism. For this purpose, overexpression of CXCR4 in C4-2B cells was confirmed with flow cytometry assays ( Figure 6A ). Overexpression of CXCR4 markedly enhanced expression of Slug, N-cadherin, and vimentin, and this was followed by decreased expression of E-cadherin ( Figure 6B ). This suggests that upregulation of CXCR4 may promote EMT. Moreover, cell stimulation by CXCL12 partially enhanced EMT, as shown by reduced expression of E-cadherin and increased production of N-cadherin. Indeed, cell treatment with the CXCR4 antagonist AMD3100 markedly inhibited EMT, as indicated by reduced Slug expression. These data suggest that the CXCL12-CXCR4 axis promotes EMT in PCa. However, overexpression of Slug had no effect on membranous CXCR4 expression (supplementary material, Figure S8 ). Finally, to further explore how the CXCR12-CXCR4 axis plays a role in promoting EMT, we analysed its downstream signalling pathways. Consistent with our previous reports [41] , the CXCR12-CXCR4 axis is related to activation of the Akt, extracellular signal-regulated kinase (ERK) 1/2 and STAT3 signalling pathways ( Figure 6C) . Notably, HIC1 silencing activated the AKT, ERK1/2 and STAT3 pathways ( Figure 6D) . Thus, HIC1 deficiency may activate the downstream pathways by upregulating CXCR4 expression. Interestingly, when we used inhibitors targeting these pathways, only the ERK1/2 inhibitor U0126 significantly inhibited the expression of Slug and N-cadherin, and enhanced E-cadherin expression ( Figure 6E ).
In summary, the HIC1 promoter is hypermethylated in PCa, which reduces its expression, especially in metastatic PCa tissues. HIC1 loss promotes EMT and metastasis by upregulating Slug and CXCR4 expression. Moreover, EMT is positively modulated by the CXCL12-CXCR4 axis through activation of the ERK1/2 pathway. These effects of epigenetic silencing of HIC1 on PCa metastasis are illustrated in Figure 6F .
Discussion
EMT has been widely documented to play a critical role in the process of PCa metastasis [39, 40] . In vivo studies have shown that activation of K-ras significantly418 M Hao et al cascade [39] . A role for HIC1 in modulating the EMT programme has been recently reported in oesophageal squamous cell carcinoma, through increased EPHA2 expression [43] .
We have identified Slug as an EMT mediator that is upregulated upon HIC1 loss. The Slug gene (SNAI2) encodes a zinc-finger transcription factor from the Snail superfamily, which induces EMT by inhibiting the E-cadherin promoter [44] . Many studies have reported that Slug confers proinvasive and prometastatic phenotypes on PCa cells in vitro and in vivo, and that its expression is increased in advanced-stage PCa tissues [14, 15, 45] . Here, we found that Slug silencing significantly reduced invasion and metastasis of C4-2B shHIC1 cells in vitro and in vivo, and prolonged mouse survival. These data suggest that Slug plays a crucial role in PCa metastasis and/or EMT development in HIC1-deficient cells. Notably, the Slug promoter has recently been reported to be hypermethylated and its expression to be downregulated in most PCa epithelia. However, Slug expression was mainly observed at the invasive front of high-grade PCa foci [46] . This result indicates that Slug expression is highly heterogeneous in PCa epithelia. Therefore, the function of Slug in PCa progression needs to be further evaluated.
We and other groups have shown that the chemokine receptor CXCR4 is highly expressed in PCa cells and tumour tissues, and is associated with bone metastasis and poor survival [8, 47] . Preclinical research has proved that pharmacological inhibition of the CXCL12-CXCR4 axis significantly reduces the metastasis of PCa cells to bone [48] . However, long-term exposure to inhibitors that disrupt CXCL12-CXCR4 signalling might cause dysfunctions of the immune system and haematopoietic niches in cancer patients [49] . Thus, it is critical to identify upstream targets of CXCR4, as this may provide useful clues abolishing the undesirable effects in CXCR4-driven PCa metastasis. TMPRSS2-ERG gene fusion has been associated with CXCR4 expression, and ERG was able to directly activate the CXCR4 promoter [50] . Here, we found that HIC1 silencing markedly promoted PCa cell metastasis to bone, suggesting that CXCR4 may be modulated by HIC1. Indeed, HIC1 silencing in PCa cells apparently increased CXCR4 expression. Targeting the CXCL12-CXCR4 axis significantly inhibited the invasive ability of HIC1-silenced PCa cells, and restoring expression of HIC1 inhibited CXCR4 expression. Recently, miRNA-29b has been reported to restore HIC1 expression by targeting the 3 ′ -untranslated regions of the genes encoding DNA methyltransferase 3A and DNA methyltransferase 3B [51] . These observations suggest that therapies targeting epigenetic events regulating HIC1 expression may provide an effective strategy for PCa treatment.
Finally, we evaluated the relationship between EMT and CXCR4 in PCa. Interestingly, the CXCL12-CXCR4 axis was able to induce EMT by activating the ERK1/2 pathway. Similarly, a recent study using the Pten-null/K-ras-activated mouse model showed that active mitogen-activated protein kinase signalling markedly enhanced PCa metastasis and EMT development in vivo [42] .
In summary, our study suggests that evaluation of HIC1-CXCR4-Slug signalling may provide a potential predictor for PCa aggressiveness, and that reactivation of HIC1 may provide a more effective strategy for PCa treatment. Figure S1 . The HIC1 promoter is highly hypermethylated in PCa tissues in the TCGA database 
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